Showing results (1791-1800 of 2,022) with videos related to

Sort By:
Pageof 203
Acta Neuropathologica|May 18, 2021
Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumorsRajiv Pathak, Francesca Zin, Christian Thomas, et al.
Frontiers in Immunology|October 12, 2020
Postnatal Expansion, Maturation, and Functionality of MR1T Cells in HumansGwendolyn M Swarbrick, Anele Gela, Meghan E Cansler, et al.
European Journal of Immunology|April 10, 2022
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patientsStanley Kimbung Mbandi, Hannah Painter, Adam Penn-Nicholson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2020
Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis InfectionDarragh Duffy, Elisa Nemes, Alba Llibre, et al.
Frontiers in Immunology|January 2, 2023
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responsesAlba Llibre, Nikaïa Smith, Vincent Rouilly, et al.
Journal of Pediatric Surgery|January 9, 2007
Ex utero intrapartum treatment with extracorporeal membrane oxygenation for severe congenital diaphragmatic herniaShaun M Kunisaki, Carol E Barnewolt, Judy A Estroff, et al.
International Journal of Molecular Sciences|December 1, 2019
Cellular Factor XIII, a Transglutaminase in Human Corneal KeratocytesZsuzsanna Z Orosz, Helga Bárdos, Amir H Shemirani, et al.
Nature|November 1, 2018
Author Correction: A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Clinical and Translational Science|October 24, 2023
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety studyJacob M van Laar, Alejhandra Lei, Mary Safy-Khan, et al.
Pageof 203